Viking Therapeutics, INC. (VKTX) — 8-K Filings

8-K Filings (14)

• Viking Therapeutics Files 8-K on Financials — Oct 22, 2025 Risk: low
  Viking Therapeutics, Inc. filed an 8-K on October 22, 2025, reporting on its results of operations and financial condition, as well as financial statements and
• Viking Therapeutics Files 8-K Report — Aug 19, 2025 Risk: low
  On August 19, 2025, Viking Therapeutics, Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure and includes Fina
• Viking Therapeutics Files 8-K on Shareholder Votes & Exhibits — May 27, 2025 Risk: low
  Viking Therapeutics, Inc. filed an 8-K on May 27, 2025, reporting on matters submitted to a vote of security holders and financial statements/exhibits as of May
• Viking Therapeutics Files 8-K: Auditor Change — Apr 23, 2025 Risk: low
  Viking Therapeutics, Inc. filed an 8-K on April 23, 2025, reporting events as of April 18, 2025. The filing primarily concerns changes in the registrant's certi
• Viking Therapeutics Files 8-K on Material Agreement — Mar 11, 2025 Risk: medium
  On March 10, 2025, Viking Therapeutics, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company, headquartered in
• Viking Therapeutics Files 8-K on Financials — Feb 5, 2025 Risk: low
  Viking Therapeutics, Inc. filed an 8-K on February 5, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and
• Viking Therapeutics Files 8-K — Nov 4, 2024 Risk: low
  On November 4, 2024, Viking Therapeutics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the inclusion of Financial Statem
• Viking Therapeutics Files 8-K — Jun 4, 2024 Risk: low
  On June 4, 2024, Viking Therapeutics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No
• Viking Therapeutics Announces Annual Meeting Results — May 23, 2024 Risk: low
  Viking Therapeutics, Inc. announced on May 21, 2024, several key updates. The company held its Annual Meeting of Stockholders where directors were elected and a
• Viking Therapeutics Files 8-K on Operations — Apr 24, 2024 Risk: low
  Viking Therapeutics, Inc. filed an 8-K on April 24, 2024, reporting on its results of operations and financial condition. The filing includes financial statemen
• Viking Therapeutics Files 8-K — Mar 26, 2024 Risk: low
  Viking Therapeutics, Inc. filed an 8-K on March 26, 2024, to report on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not con
• Viking Therapeutics Files 8-K — Mar 4, 2024 Risk: low
  Viking Therapeutics, Inc. filed an 8-K on March 4, 2024, to report other events and financial statements. The filing does not contain specific financial figures
• Viking Therapeutics Files 8-K Report — Mar 1, 2024 Risk: low
  On February 28, 2024, Viking Therapeutics, Inc. filed an 8-K report detailing several events. The company entered into a material definitive agreement and repor
• Viking Therapeutics Files Routine 8-K for Regulatory Disclosure — Feb 27, 2024 Risk: low
  Viking Therapeutics, Inc. filed a Form 8-K with the SEC on February 27, 2024, reporting on Regulation FD Disclosure and Financial Statements and Exhibits. This

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX